10/GADD153 and adipocyte differentiation: a mechanism for hypoxia- dependent effect. J Biol Chem 279: 40462–40469. 25. Burton GR, Nagarajan R, Peterson CA, McGehee RE, Jr. (2004) Microarray analysis of differentiation-specific gene expression during 3T3-L1 adipogenesis. Gene 329: 167–185. 26. Wang P, Mariman E, Keijer J, Bouwman F, Noben JP, et al. (2004) Profiling of the secreted proteins during 3T3-L1 adipocyte differentiation leads to the identification of novel adipokines. Cell Mol Life Sci 61: 2405–2417. 27. Artal-Sanz M, Tavernarakis N (2009) Prohibitin couples diapause signalling to mitochondrial metabolism during ageing in C. elegans. Nature 461: 793–797. 28. Liu D, Hou J, Hu X, Wang X, Xiao Y, et al. (2006) Neuronal chemorepellent Slit2 inhibits vascular smooth muscle cell migration by suppressing small GTPase Rac1 activation. Circ Res 98: 480–489. 29. Wu JJ, Roth RJ, Anderson EJ, Hong EG, Lee MK, et al. (2006) Mice lacking MAP kinase phosphatase-1 have enhanced MAP kinase activity and resistance to diet-induced obesity. Cell Metab 4: 61–73. 30. Nadler ST, Stoehr JP, Schueler KL, Tanimoto G, Yandell BS, et al. (2000) The expression of adipogenic genes is decreased in obesity and diabetes mellitus. Proc Natl Acad Sci U S A 97: 11371–11376. 31. Rajalingam K, Wunder C, Brinkmann V, Churin Y, Hekman M, et al. (2005) Prohibitin is required for Ras-induced Raf-MEK-ERK activation and epithelial cell migration. Nat Cell Biol 7: 837–843. 32. Prusty D, Park BH, Davis KE, Farmer SR (2002) Activation of MEK/ERK signaling promotes adipogenesis by enhancing peroxisome proliferator-activated receptor gamma (PPARgamma ) and C/EBPalpha gene expression during the differentiation of 3T3-L1 preadipocytes. J Biol Chem 277: 46226–46232. 33. Bost F, Aouadi M, Caron L, Binetruy B (2005) The role of MAPKs in adipocyte differentiation and obesity. Biochimie 87: 51–56. 34. Ande SR, Xu Z, Gu Y, Mishra S (2011) Prohibitin has an important role in adipocyte differentiation. Int J Obes (Lond). 35. De Pauw A, Tejerina S, Raes M, Keijer J, Arnould T (2009) Mitochondrial (dys)function in adipocyte (de)differentiation and systemic metabolic alterations. Am J Pathol 175: 927–939. 36. Bogenhagen DF, Rousseau D, Burke S (2008) The layered structure of human mitochondrial DNA nucleoids. J Biol Chem 283: 3665–3675. 37. Wang Y, Bogenhagen DF (2006) Human mitochondrial DNA nucleoids are linked to protein folding machinery and metabolic enzymes at the mitochondrial inner membrane. J Biol Chem 281: 25791–25802. 38. Osman C, Merkwirth C, Langer T (2009) Prohibitins and the functional compartmentalization of mitochondrial membranes. J Cell Sci 122: 3823–3830. 39. Merkwirth C, Langer T (2009) Prohibitin function within mitochondria: essential roles for cell proliferation and cristae morphogenesis. Biochim Biophys Acta 1793: 27–32. Prohibitins Are Required for Adipogenesis 40. Park SE, Xu J, Frolova A, Liao L, O’Malley BW, et al. (2005) Genetic deletion of the repressor of estrogen receptor activity (REA) enhances the response to estrogen in target tissues in vivo. Mol Cell Biol 25: 1989–1999. 41. Vessal M, Mishra S, Moulik S, Murphy LJ (2006) Prohibitin attenuates insulin- stimulated glucose and fatty acid oxidation in adipose tissue by inhibition of pyruvate carboxylase. FEBS J 273: 568–576. 42. Smith PJ, Wise LS, Berkowitz R, Wan C, Rubin CS (1988) Insulin-like growth factor-I is an essential regulator of the differentiation of 3T3-L1 adipocytes. J Biol Chem 263: 9402–9408. 43. Mawson A, Lai A, Carroll JS, Sergio CM, Mitchell CJ, et al. (2005) Estrogen and insulin/IGF-1 cooperatively stimulate cell cycle progression in MCF-7 breast cancer cells through differential regulation of c-Myc and cyclin D1. Mol Cell Endocrinol 229: 161–173. 44. Menssen A, Hermeking H (2002) Characterization of the c-MYC-regulated transcriptome by SAGE: identification and analysis of c-MYC target genes. Proc Natl Acad Sci U S A 99: 6274–6279. 45. Cao Z, Umek RM, McKnight SL (1991) Regulated expression of three C/EBP isoforms during adipose conversion of 3T3-L1 cells. Genes Dev 5: 1538–1552. 46. Nijtmans LG, Artal SM, Grivell LA, Coates PJ (2002) The mitochondrial PHB complex: roles in mitochondrial respiratory complex assembly, ageing and degenerative disease. Cell Mol Life Sci 59: 143–155. 47. Mishra S, Murphy LC, Murphy LJ (2006) The Prohibitins: emerging roles in diverse functions. J Cell Mol Med 10: 353–363. 48. Coates PJ, Jamieson DJ, Smart K, Prescott AR, Hall PA (1997) The prohibitin family of mitochondrial proteins regulate replicative lifespan. Curr Biol 7: 607–610. 49. Chowdhury I, Garcia-Barrio M, Harp D, Thomas K, Matthews R, et al. (2012) The emerging roles of prohibitins in folliculogenesis. Front Biosci (Elite Ed) 4: 690–699. 50. Rajalingam K, Rudel T (2005) Ras-Raf signaling needs prohibitin. Cell Cycle 4: 1503–1505. 51. Marshall CJ (1995) Specificity of receptor tyrosine kinase signaling: transient versus sustained extracellular signal-regulated kinase activation. Cell 80: 179–185. 52. Sripathi SR, He W, Atkinson CL, Smith JJ, Liu Z, et al. (2011) Mitochondrial- nuclear communication by prohibitin shuttling under oxidative stress. Biochemistry 50: 8342–8351. 53. Heron-Milhavet L, Mamaeva D, Rochat A, Lamb NJ, Fernandez A (2008) Akt2 is implicated in skeletal muscle differentiation and specifically binds Prohibitin2/ REA. J Cell Physiol 214: 158–165. 54. Hoppins S, Lackner L, Nunnari J (2007) The machines that divide and fuse mitochondria. Annu Rev Biochem 76: 751–780. PLoS ONE | www.plosone.org 10 March 2012 | Volume 7 | Issue 3 | e34315